These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 16520374

  • 21. VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins.
    Couvineau A, Laburthe M.
    Br J Pharmacol; 2012 May; 166(1):42-50. PubMed ID: 21951273
    [Abstract] [Full Text] [Related]

  • 22. Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor.
    Marie JC, Rouyer-Fessard C, Couvineau A, Nicole P, Devaud H, El Benna J, Laburthe M.
    Mol Pharmacol; 2003 Dec; 64(6):1565-74. PubMed ID: 14645688
    [Abstract] [Full Text] [Related]

  • 23. Characterization of the new photoaffinity probe (Bz2-K24)-VIP.
    Tan YV, Couvineau A, Lacapere JJ, Laburthe M.
    Ann N Y Acad Sci; 2006 Jul; 1070():575-80. PubMed ID: 16888228
    [Abstract] [Full Text] [Related]

  • 24. Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition.
    Van Rampelbergh J, Juarranz MG, Perret J, Bondue A, Solano RM, Delporte C, De Neef P, Robberecht P, Waelbroeck M.
    Br J Pharmacol; 2000 Jun; 130(4):819-26. PubMed ID: 10864888
    [Abstract] [Full Text] [Related]

  • 25. Molecular approximations between residues 21 and 23 of secretin and its receptor: development of a model for peptide docking with the amino terminus of the secretin receptor.
    Dong M, Lam PC, Gao F, Hosohata K, Pinon DI, Sexton PM, Abagyan R, Miller LJ.
    Mol Pharmacol; 2007 Aug; 72(2):280-90. PubMed ID: 17475809
    [Abstract] [Full Text] [Related]

  • 26. Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors.
    Vertongen P, Langlet C, Langer I, Gaspard N, Robberecht P.
    Peptides; 2004 Nov; 25(11):1943-9. PubMed ID: 15501526
    [Abstract] [Full Text] [Related]

  • 27. Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP.
    Laburthe M, Couvineau A.
    Regul Pept; 2002 Oct 15; 108(2-3):165-73. PubMed ID: 12220741
    [Abstract] [Full Text] [Related]

  • 28. Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands.
    Juarranz MG, Van Rampelbergh J, Gourlet P, De Neef P, Cnudde J, Robberecht P, Waelbroeck M.
    Mol Pharmacol; 1999 Dec 15; 56(6):1280-7. PubMed ID: 10570056
    [Abstract] [Full Text] [Related]

  • 29. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
    Nachtergael I, Gaspard N, Langlet C, Robberecht P, Langer I.
    Cell Signal; 2006 Dec 15; 18(12):2121-30. PubMed ID: 16650965
    [Abstract] [Full Text] [Related]

  • 30. A Molecular Dynamics Study of Vasoactive Intestinal Peptide Receptor 1 and the Basis of Its Therapeutic Antagonism.
    Latek D, Langer I, Krzysko K, Charzewski L.
    Int J Mol Sci; 2019 Sep 05; 20(18):. PubMed ID: 31491880
    [Abstract] [Full Text] [Related]

  • 31. Spatial approximation between secretin residue five and the third extracellular loop of its receptor provides new insight into the molecular basis of natural agonist binding.
    Dong M, Lam PC, Pinon DI, Sexton PM, Abagyan R, Miller LJ.
    Mol Pharmacol; 2008 Aug 05; 74(2):413-22. PubMed ID: 18467541
    [Abstract] [Full Text] [Related]

  • 32. [Physiological significance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the nervous system].
    Hashimoto H.
    Yakugaku Zasshi; 2002 Dec 05; 122(12):1109-21. PubMed ID: 12510388
    [Abstract] [Full Text] [Related]

  • 33. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
    Schulz S, Röcken C, Mawrin C, Weise W, Höllt V, Schulz S.
    Clin Cancer Res; 2004 Dec 15; 10(24):8235-42. PubMed ID: 15623599
    [Abstract] [Full Text] [Related]

  • 34. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G, Malendowicz LK, Neri G, Andreis PG, Ziolkowska A, Gottardo L, Nowak KW, Nussdorfer GG.
    Int J Mol Med; 2002 Mar 15; 9(3):233-43. PubMed ID: 11836629
    [Abstract] [Full Text] [Related]

  • 35. Localisation of VIP-binding sites exhibiting properties of VPAC receptors in chromaffin cells of rainbow trout (Oncorhynchus mykiss).
    Montpetit CJ, Shahsavarani A, Perry SF.
    J Exp Biol; 2003 Jun 15; 206(Pt 11):1917-27. PubMed ID: 12728013
    [Abstract] [Full Text] [Related]

  • 36. Structural and functional identification of the pituitary adenylate cyclase-activating polypeptide receptor VPAC2 from the frog Rana tigrina rugulosa.
    Hoo RL, Alexandre D, Chan SM, Anouar Y, Pang RT, Vaudry H, Chow BK.
    J Mol Endocrinol; 2001 Oct 15; 27(2):229-38. PubMed ID: 11564605
    [Abstract] [Full Text] [Related]

  • 37. Effect of positive charge in VIP 16gamma-glutamyl diamino derivatives on hVPAC1 and hVPAC2 receptor function.
    de Maria S, Metafora V, Metafora S, Ravagnan G, Cartení M, Pontoni G, Facchiano A, Lepretti M, Severino B, Caliendo G, Santagada V, Langer I, Robberecht P.
    J Pept Sci; 2008 Jan 15; 14(1):102-9. PubMed ID: 17883247
    [Abstract] [Full Text] [Related]

  • 38. Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation.
    Perret J, Vertongen P, Solano RM, Langer I, Cnudde J, Robberecht P, Waelbroeck M.
    Br J Pharmacol; 2002 Aug 15; 136(7):1042-8. PubMed ID: 12145104
    [Abstract] [Full Text] [Related]

  • 39. Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor.
    Gourlet P, Vilardaga JP, De Neef P, Vandermeers A, Waelbroeck M, Bollen A, Robberecht P.
    Eur J Biochem; 1996 Jul 15; 239(2):349-55. PubMed ID: 8706739
    [Abstract] [Full Text] [Related]

  • 40. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems.
    Arimura A.
    Jpn J Physiol; 1998 Oct 15; 48(5):301-31. PubMed ID: 9852340
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.